Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
Public ClinicalTrials.gov record NCT02769481. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-blind, Active-controlled Study to Evaluate the Effects of Bexagliflozin Versus Glimepiride in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control by Metformin
Study identification
- NCT ID
- NCT02769481
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Theracos
- Industry
- Enrollment
- 426 participants
Conditions and interventions
Conditions
Interventions
- Bexagliflozin Drug
- Placebo for Bexagliflozin Drug
- Glimepiride Drug
- Placebo for Glimepiride Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 14, 2016
- Primary completion
- Jun 13, 2019
- Completion
- Jun 13, 2019
- Last update posted
- May 26, 2021
2016 – 2019
United States locations
- U.S. sites
- 11
- U.S. states
- 5
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | 35205 | — |
| Research Site | Huntington Park | California | 90255 | — |
| Research Site | Los Angeles | California | 90057 | — |
| Research Site | San Carlos | California | 94070 | — |
| Research Site | Hialeah | Florida | 33012 | — |
| Research Site | Miami Lakes | Florida | 33016 | — |
| Research Site | Orlando | Florida | 32806 | — |
| Research Site | West Palm Beach | Florida | 33401 | — |
| Research Site | Calabash | North Carolina | 28467 | — |
| Research Site | Morehead City | North Carolina | 28557 | — |
| Research Site | Magnolia | Texas | 77355 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 34 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02769481, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 26, 2021 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02769481 live on ClinicalTrials.gov.